1. Home
  2. CINF vs NTRA Comparison

CINF vs NTRA Comparison

Compare CINF & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cincinnati Financial Corporation

CINF

Cincinnati Financial Corporation

HOLD

Current Price

$159.84

Market Cap

25.0B

Sector

Finance

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$204.80

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINF
NTRA
Founded
1950
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0B
28.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CINF
NTRA
Price
$159.84
$204.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
14
Target Price
$177.25
$259.07
AVG Volume (30 Days)
559.5K
1.1M
Earning Date
04-27-2026
05-07-2026
Dividend Yield
2.37%
N/A
EPS Growth
4.40
0.65
EPS
15.17
N/A
Revenue
$12,631,000,000.00
$210,939,000.00
Revenue This Year
N/A
$18.16
Revenue Next Year
$6.97
$20.00
P/E Ratio
$10.44
N/A
Revenue Growth
11.41
N/A
52 Week Low
$123.02
$130.29
52 Week High
$174.27
$256.36

Technical Indicators

Market Signals
Indicator
CINF
NTRA
Relative Strength Index (RSI) 48.98 53.10
Support Level $151.48 $194.03
Resistance Level $168.35 $251.09
Average True Range (ATR) 3.22 7.50
MACD 0.05 2.09
Stochastic Oscillator 41.92 80.56

Price Performance

Historical Comparison
CINF
NTRA

About CINF Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: